• Trials and Research

  Phase 3 Trials of Fenebrutinib Enrolling Relapsing MS, PPMS Patients

  Posted by ms-news-today-moderator on May 26, 2021 at 10:05 am

  

  Global trials in relapsing and primary progressive MS are underway comparing oral fenebrutinib to Aubagio (relapsing MS) or Ocrevus (PPMS). Click here to find out more.

  Will you be following these trials closely?

  ms-news-today-moderator replied 2 years, 10 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply